At all examined time points, VEGF-A serum levels have been found to be significantly higher than EDTA plasma values, both for breast cancer patients (p < 0.0001) and healthy controls (p < 0.0001) as can be seen in Fig. 1. Here, VEGFA is linked to breast carcinoma.